An Xu Biotech's announcement on the response to the inquiry letter on the 2023 annual report of the Shanghai Stock Exchange
Minsheng Securities Co., Ltd.'s verification opinion on An Xu Biotech's 2023 Annual Report Information Disclosure Regulatory Inquiry Letter
Response from CCIC Zhonghuan Certified Public Accountants to the inquiry letter on An Xu Biotech's 2023 report
Minsheng Securities Co., Ltd. site inspection report on Hangzhou Anxu Biotechnology Co., Ltd.'s 2023 continuous supervision work site
Anxu Biotech Investor Relations Activity Record Form 20240516
An Xu Biotech's announcement on holding the 2023 and first quarter 2024 results briefings
2023 Independent Director Debriefing Report (Chapter Guobao)
2023 Independent Director Debriefing Report (Ma Weimin)
Minsheng Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Hangzhou Anxu Biotechnology Co., Ltd.
Articles of Association of Hangzhou Anxu Biotechnology Co., Ltd. (202404)
Announcement on the renewal of the 2024 Audit Institution
Special report on the storage and actual use of funds raised in 2023
Special inspection opinion of Minsheng Securities Co., Ltd. on the deposit and use of funds raised by Hangzhou Anxu Biotechnology Co., Ltd. in 2023
China Audit Zhonghuan Certified Public Accountants (Special General Partnership) Audit Report on the Annual Storage and Use of Funds Raised by An Xu Biotech
Feasibility analysis report on developing forward foreign exchange settlement and foreign exchange derivatives business
Minsheng Securities Co., Ltd. Minsheng Securities's inspection opinions on Hangzhou Anxu Biotechnology Co., Ltd.'s forward foreign exchange settlement business
Notice on changes in accounting policies
Announcement of Resolutions of the 11th Meeting of the 2nd Board of Supervisors
2023 Accounting Firm Performance Assessment Report
China Audit Zhonghuan Certified Public Accountants (Special General Partnership) on An Xu Biotech's 2023 Audit Report
No Data